Figure 2
From: Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin
Pharmacokinetics of MOC31PE alone. The plasma levels of MOC31PE were analysed at time points 3, 6, 12, 24 and 48 h after i.v. injection of MOC31PE. The dose of MOC31PE was 3, 4, 5 and 6.5 μg kg−1 (n=2–3 patients/time point). Non-parametric testing using the Mann–Whitney Rank sum test on each dose level does not detect any significant difference between the groups.
